SCHEMBL12349342

SCHEMBL12349342

O=S1(=O)c2ccccc2N(CC[Si](c2ccccc2)(c2ccccc2)c2ccc(-n3c4ccccc4c4ccccc43)cc2)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 6/20 0.38
THRB P10828 1/20 0.38
TP53 P04637 3/20 0.36
MAPT P10636 3/20 0.35
POLB P06746 1/20 0.35
HTR1A P08908 1/20 0.34
HTR2A P28223 1/20 0.34
HTR7 P34969 1/20 0.34
HTR6 P50406 1/20 0.34
PTPN1 P18031 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HDAC1 Q13547 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
HDAC3 O15379 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12349337 0.85 RXFP1 (0.54) RXFP1MEN1KMT2ALMNATHRB
SCHEMBL12349317 0.78 KDM4E (0.42) RXFP1MEN1KMT2AKDM4EATM
SCHEMBL12349332 0.74 KDM4E (0.39) RXFP1MEN1KMT2AKDM4EATM
SCHEMBL12349318 0.74 KDM4E (0.40) RXFP1MEN1KMT2AKDM4EATM
SCHEMBL12349338 0.74 RXFP1 (0.54) RXFP1MEN1KMT2ALMNATHRB
SCHEMBL12349325 0.72 KDM4E (0.36) RXFP1MEN1KMT2AKDM4EATM
SCHEMBL12349343 0.71 MAPT (0.46) RXFP1MEN1KMT2ALMNATHRB
SCHEMBL12349333 0.71 KDM4E (0.36) RXFP1KDM4EATML3MBTL1LMNA
SCHEMBL12349341 0.70 RXFP1 (0.56) RXFP1MEN1KMT2ALMNATHRB
SCHEMBL12349326 0.68 KDM4E (0.33) RXFP1KDM4EATML3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989091-B2 Silanes containing phenothiazine-S-oxide or phenothiazine-S,S-dioxide groups and the use thereof in OLEDs BASF SE (DE) 2011-08-02 US disclosed
US-20100187980-A1 SILANES CONTAINING PHENOTHIAZINE-S-OXIDE OR PHENOTHIAZINE-S,S-DIOXIDE GROUPS AND THE USE THEREOF IN OLEDS BASF SE (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100187980-A1 SILANES CONTAINING PHENOTHIAZINE-S-OXIDE OR PHENOTHIAZINE-S,S-DIOXIDE GROUPS AND THE USE THEREOF IN OLEDS OPRD1, PPID, PLOD2 RXFP1 4373/4885MEN1 4705/4885KMT2A 1446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.